QA: RAPT Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001673772_2021_RAPT_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001673772, RAPT Therapeutics Inc

  xvar xval
0 AssetsCurrent 115,598,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,982,000
3 remainder_Assets 389,000
4 LiabilitiesCurrent 11,742,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,048,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,771,000
9 ResearchAndDevelopmentExpense 45,485,000
10 remainder_Expenses 990,000
11 remainder_Revenues 5,042,000
12 remainder_NetIncome 1,312,000
13 remainder_ComprehensiveNetIncome -197,000
  yvar yval
0 Assets 118,969,000
1 Liabilities 14,790,000
2 Expenses 59,246,000
3 Revenues 5,042,000
4 StockholdersEquity 104,179,000
5 NetIncome -52,892,000
6 ComprehensiveNetIncome -52,990,500
7 BaseVar 99,778,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.60
9 EconomicCapitalRatio 3.42

Edgar->Model Mapping

Feature Distribution